Opsonic phagocytosis of Streptococcus pneumoniae by alveolar macrophages is not impaired in human immunodeficiency virus infected Malawian adults

被引:24
作者
Gordon, SB
Molyneux, ME
Boeree, MJ
Kanyanda, S
Chaponda, M
Squire, SB
Read, RC
机构
[1] Univ Malawi, Coll Med, Queen Elizabeth Cent Hosp, Wellcome Trust Res Labs,Dept Med, Blantyre, Malawi
[2] Univ Malawi, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi
[3] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England
[4] Univ Sheffield, Sch Med, Royal Hallamshire Hosp, Div Genom Med, Sheffield, S Yorkshire, England
基金
英国惠康基金;
关键词
D O I
10.1086/324080
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Streptococcus pneumoniae is a major cause of pneumonia, bacteremia, and meningitis, especially among adults infected with the human immunodeficiency virus (HIV). Alveolar macrophages (AMs) are critical components of cellular defense against bacterial infection and are both infected and affected by HIV. In this study, AMs obtained at bronchoscopy from 44 Malawian adults (24 HIV positive and 20 HIV negative) were exposed in vitro to opsonized S. pneumoniae and coagulase-negative staphylococci. AMs from HIV-positive and -negative volunteers showed no significant difference in binding to or internalization of either S. pneumoniae or coagulase-negative staphylococci. In HIV-positive subjects, the presence of detectable HIV in lung fluid was not associated with AM impairment. AMs from HIV-infected adults did not exhibit impaired pneumococcal phagocytosis in the assay used. This suggests that an alternative mechanism of susceptibility is operating in these individuals.
引用
收藏
页码:1345 / 1349
页数:5
相关论文
共 15 条
[1]   Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice [J].
Bergeron, Y ;
Ouellet, N ;
Deslauriers, AM ;
Simard, M ;
Olivier, M ;
Bergeron, MG .
INFECTION AND IMMUNITY, 1998, 66 (03) :912-922
[2]   Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense [J].
Chen, GH ;
Reddy, RC ;
Newstead, MW ;
Tateda, K ;
Kyasapura, BL ;
Standiford, TJ .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6496-6503
[3]  
COONROD JD, 1990, J LAB CLIN MED, V116, P354
[4]   Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine [J].
Feikin, DR ;
Dowell, SF ;
Nwanyanwu, OC ;
Klugman, KP ;
Kazembe, PN ;
Barat, LM ;
Graf, C ;
Bloland, PB ;
Ziba, C ;
Huebner, RE ;
Schwartz, B .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (04) :1501-1505
[5]   23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial [J].
French, N ;
Nakiyingi, J ;
Carpenter, LM ;
Lugada, E ;
Watera, C ;
Moi, K ;
Moore, M ;
Antvelink, D ;
Mulder, D ;
Janoff, EN ;
Whitworth, J ;
Gilks, CF .
LANCET, 2000, 355 (9221) :2106-2111
[6]   Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya [J].
Gilks, CF ;
Ojoo, SA ;
Ojoo, JC ;
Brindle, RJ ;
Paul, J ;
Batchelor, BIF ;
Kimari, JN ;
Newnham, R ;
Bwayo, J ;
Plummer, FA ;
Warrell, DA .
LANCET, 1996, 347 (9003) :718-723
[7]   Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins [J].
Gordon, SB ;
Irving, GRB ;
Lawson, RA ;
Lee, ME ;
Read, RC .
INFECTION AND IMMUNITY, 2000, 68 (04) :2286-2293
[8]  
HOF DG, 1980, AM REV RESPIR DIS, V121, P65
[9]   Human immunodeficiency virus type 1 infection of alveolar macrophages impairs their innate fungicidal activity [J].
Ieong, MH ;
Reardon, CC ;
Levitz, SM ;
Kornfeld, H .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (03) :966-970
[10]   HUMAN ALVEOLAR LINING MATERIAL AND ANTIBACTERIAL DEFENSES [J].
JONSSON, S ;
MUSHER, DM ;
GOREE, A ;
LAWRENCE, EC .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 133 (01) :136-140